news Osimertinib resistance explained by computer simulations 15 February 2018 | By Dr Zara Kassam (Drug Target Review) Scientists have used molecular simulations to understand the resistance to osimertinib - an anticancer drug used to treat types of lung cancer...
news NRF2 pathway provides new approach to cancer drug discovery 2 October 2017 | By Dr Zara Kassam (Drug Target Review) Scientists have developed a promising new strategy for the discovery of novel anti-cancer therapies for non-small-cell lung cancers...